In the News

• October 2014

  RoundTable Healthcare Partners Announces Sale of Tower Holdings, Inc. and Lineage Therapeutics Inc. to Impax Laboratories, Inc.

  LAKE FOREST, IL, October 9, 2014 – RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has entered into a definitive agreement to sell Tower Holdings, Inc. (“Tower”), including operating subsidiaries CorePharma LLC (“CorePharma”) and Amedra Pharmaceuticals LLC (“Amedra”) and Lineage Therapeutics Inc. (“Lineage”) (together, the “Companies”) to Impax Laboratories Inc. (“Impax”), a leading, technology-based specialty pharmaceutical company, for $700 million in cash. The closing is conditional on regulatory approval and other customary closing conditions.

  more

• September 2014

  RoundTable Healthcare Partners and Argon Medical Devices Complete Acquisition of US Biopsy

  LAKE FOREST, IL, September 9, 2014 – RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that its portfolio company, Argon Medical Devices, Inc. (“Argon”), a leading manufacturer of specialty medical devices, has completed the acquisition of Promex Technologies, LLC (d/b/a “US Biopsy”), the manufacturer of the TLAB® transjugular liver biopsy device (“TLAB”) and other soft tissue biopsy devices and needles. The financial terms of the transaction were not disclosed.

  more

• August 2014

  RoundTable Healthcare Partners Announces Sale of Vesta Funding, Inc. to The Lubrizol Corporation

  LAKE FOREST, IL, August 1, 2014 – RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today the sale of Vesta Funding, Inc. (“Vesta”) to The Lubrizol Corporation (“Lubrizol”). Lubrizol, a Berkshire Hathaway company, is a specialty chemical company that produces and supplies technologies to customers in the global transportation, industrial and consumer markets. Terms of the transaction were not disclosed.

  more

• January 2014

  RoundTable Announces 3rd Recipient of the Robert DeBaun Humanitarian Award

  LAKE FOREST, IL, January 16, 2014 – RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has completed the sale of Aqua Pharmaceuticals Holdings, Inc. (“Aqua”) to Almirall S.A (“Almirall”) for up to $402.6 million in cash. The consideration includes $327.6 million of cash at closing plus up to $75 million of contingent payments. Almirall, headquartered in Barcelona, Spain, is a global pharmaceutical company committed to providing innovative products focused on the treatment of respiratory, dermatological, gastrointestinal and pain diseases.

  more